1. Home
  2. ORKA vs ATUS Comparison

ORKA vs ATUS Comparison

Compare ORKA & ATUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKA
  • ATUS
  • Stock Information
  • Founded
  • ORKA 2004
  • ATUS 2015
  • Country
  • ORKA United States
  • ATUS United States
  • Employees
  • ORKA N/A
  • ATUS N/A
  • Industry
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ATUS Cable & Other Pay Television Services
  • Sector
  • ORKA Health Care
  • ATUS Telecommunications
  • Exchange
  • ORKA Nasdaq
  • ATUS Nasdaq
  • Market Cap
  • ORKA 1.0B
  • ATUS 1.2B
  • IPO Year
  • ORKA N/A
  • ATUS 2017
  • Fundamental
  • Price
  • ORKA $12.25
  • ATUS $2.77
  • Analyst Decision
  • ORKA Strong Buy
  • ATUS Hold
  • Analyst Count
  • ORKA 6
  • ATUS 10
  • Target Price
  • ORKA $43.60
  • ATUS $2.39
  • AVG Volume (30 Days)
  • ORKA 413.1K
  • ATUS 2.8M
  • Earning Date
  • ORKA 02-15-2025
  • ATUS 02-13-2025
  • Dividend Yield
  • ORKA N/A
  • ATUS N/A
  • EPS Growth
  • ORKA N/A
  • ATUS N/A
  • EPS
  • ORKA N/A
  • ATUS N/A
  • Revenue
  • ORKA N/A
  • ATUS $9,021,002,000.00
  • Revenue This Year
  • ORKA N/A
  • ATUS N/A
  • Revenue Next Year
  • ORKA N/A
  • ATUS N/A
  • P/E Ratio
  • ORKA N/A
  • ATUS N/A
  • Revenue Growth
  • ORKA N/A
  • ATUS N/A
  • 52 Week Low
  • ORKA $12.24
  • ATUS $1.52
  • 52 Week High
  • ORKA $53.88
  • ATUS $3.18
  • Technical
  • Relative Strength Index (RSI)
  • ORKA N/A
  • ATUS 62.13
  • Support Level
  • ORKA N/A
  • ATUS $2.30
  • Resistance Level
  • ORKA N/A
  • ATUS $2.66
  • Average True Range (ATR)
  • ORKA 0.00
  • ATUS 0.13
  • MACD
  • ORKA 0.00
  • ATUS 0.03
  • Stochastic Oscillator
  • ORKA 0.00
  • ATUS 92.16

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

About ATUS Altice USA Inc.

Altice Europe acquired privately held us cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4 million U.S. homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York and i24News, a news operation focused on the Middle East.

Share on Social Networks: